O&039;leary v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedSeptember 6, 2024
Docket21-2249V
StatusUnpublished

This text of O&039;leary v. Secretary of Health and Human Services (O&039;leary v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
O&039;leary v. Secretary of Health and Human Services, (uscfc 2024).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 21-2249V

ERIN O’LEARY, Chief Special Master Corcoran Petitioner, v. Filed: August 5, 2024

SECRETARY OF HEALTH AND HUMAN SERVICES,

Respondent.

Jonathan Joseph Svitak, Shannon Law Group, P.C., Woodridge, IL, for Petitioner.

Jamica Marie Littles, U.S. Department of Justice, Washington, DC, for Respondent.

DECISION DISMISSING CASE1

On December 2, 2021, Erin O’Leary filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she suffered a left shoulder injury related to vaccine administration (“SIRVA”), a defined Table Injury, after receiving an influenza (“flu”) vaccine on October 27, 2020. Petition at 1, ¶ 2, 18.

However, the record in this case contains insufficient evidence to establish the pain onset within the timeframe required for a Table SIRVA, or even to support a causal link between Petitioner’s left shoulder pain and the vaccination she received. See 42 C.F.R. § 100.3(a)XIV(B) & (c)(10)((ii) (2017) (requiring pain onset within 48 hours of vaccination);

1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made

publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease

of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2018). Althen v. Sec’y of Health & Hum. Servs., 418 F.3d 1274, 1278 (Fed. Cir. 2005) (three- pronged test for actual causation). And despite due opportunity, Petitioner has not provided the preponderant evidence needed to overcome these deficiencies. I therefore DENY entitlement in this case.

I. Relevant Procedural History

Along with her petition, Ms. O’Leary filed only a declaration signed under penalty of perjury as required by 28 U.S.C.A. § 1746. Exhibit 1. Over the subsequent 16-month period, she filed the medical records required by the Vaccine Act, as well as supporting signed declarations from her son and fiancée.3 Exhibits 2-12, ECF Nos. 6, 9, 14, 17, 21. On April 4, 2023, the case was activated and assigned to the “Special Processing Unit” (OSM’s adjudicatory system for resolution of cases deemed likely to settle). ECF No. 23.

Almost one year later, on March 15, 2024, Respondent stated that he intended to oppose compensation. Status Report, ECF No. 27. On April 29, 2024, he filed his Rule 4(c) Report setting forth his objections. ECF No. 28. Emphasizing Petitioner’s initial description of gradually increasing pain, report of recent exercise, and failure to mention the flu vaccine until almost 22 months post-vaccination (eight months after the petition’s filing), Respondent maintains Petitioner has not established the pain onset needed for a Table SIRVA. Id. at 4-5. He also insists that Petitioner has failed to provide adequate evidence of causation and thus, cannot prevail pursuant to a non-Table claim. Id. at 5-6.

On May 15, 2024, I issued an Order to Show Cause, allowing Petitioner a final chance to obtain and to file the evidence needed to support her allegations. ECF No. 30. After receiving an extension of time until July 22, 2024 (ECF No. 31), Petitioner has failed to provide any additional evidence.

The matter is now ripe for adjudication.

II. Applicable Legal Standards

Under Section 13(a)(1)(A) of the Act, a petitioner must demonstrate, by a preponderance of the evidence, that all requirements for a petition set forth in section 11(c)(1) have been satisfied. A petitioner may prevail on her claim if the vaccinee for whom she seeks compensation has “sustained, or endured the significant aggravation of any illness, disability, injury, or condition” set forth in the Vaccine Injury Table (the Table). Section 11(c)(1)(C)(i). According to the most recent version of the Table, a SIRVA is

3 These declarations also were signed under penalty of perjury as required by 28 U.S.C.A. § 1746. Exhibits

8-9.

2 compensable if it manifests within 48 hours of the administration of an influenza vaccine. 42 C.F.R. § 100.3(a)(XIV)(B). The specific criteria establishing a SIRVA are as follows:

Shoulder injury related to vaccine administration (SIRVA). SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. These symptoms are thought to occur as a result of unintended injection of vaccine antigen or trauma from the needle into and around the underlying bursa of the shoulder resulting in an inflammatory reaction. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder (e.g. tendons, ligaments, bursae, etc). SIRVA is not a neurological injury and abnormalities on neurological examination or nerve conduction studies (NCS) and/or electromyographic (EMG) studies would not support SIRVA as a diagnosis (even if the condition causing the neurological abnormality is not known). A vaccine recipient shall be considered to have suffered SIRVA if such recipient manifests all of the following:

(i) No history of pain, inflammation or dysfunction of the affected shoulder prior to intramuscular vaccine administration that would explain the alleged signs, symptoms, examination findings, and/or diagnostic studies occurring after vaccine injection;

(ii) Pain occurs within the specified time frame;

(iii) Pain and reduced range of motion are limited to the shoulder in which the intramuscular vaccine was administered; and

(iv) No other condition or abnormality is present that would explain the patient’s symptoms (e.g. NCS/EMG or clinical evidence of radiculopathy, brachial neuritis, mononeuropathies, or any other neuropathy).

42 C.F.R. § 100.3(c)(10) (additional requirements set forth in the Qualifications and Aids to Interpretations (“QAI”)). If a petitioner establishes that the vaccinee has suffered a “Table Injury,” causation is presumed.

If, however, the vaccinee suffered an injury that either is not listed in the Table or did not occur within the prescribed time frame, petitioner must prove that the administered vaccine caused injury to receive Program compensation on behalf of the vaccinee. Section 11(c)(1)(C)(ii) and (iii).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
O&039;leary v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/o039leary-v-secretary-of-health-and-human-services-uscfc-2024.